Table of Contents
• Anal Cancer overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Anal Cancer Market
• Global Epidemiology of Anal Cancer Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Anal Cancer Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Anal Cancer (2013-2023)
• Table 7: Anal Cancer Global Market (USD Millions), (2013-2015)
• Table 8: Anal Cancer Global Market (USD Millions), (2016-2023)
• Table 9: Anal Cancer US Market (USD Millions), (2013-2015)
• Table 10: Anal Cancer US Market (USD Millions), (2016-2023)
• Table 11: Anal Cancer Germany Market (USD Millions), (2013-2015)
• Table 12: Anal Cancer Germany Market (USD Millions), (2016-2023)
• Table 13: Anal Cancer United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Anal Cancer United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Anal Cancer France Market (USD Millions), (2013-2015)
• Table 16: Anal Cancer France Market (USD Millions), (2016-2023)
• Table 17: Anal Cancer Italy Market (USD Millions), (2013-2015)
• Table 18: Anal Cancer Italy Market (USD Millions), (2016-2023)
• Table 19: Anal Cancer Spain Market (USD Millions), (2013-2015)
• Table 20: Anal Cancer Spain Market (USD Millions), (2016-2023)
• Table 21: Anal Cancer Japan Market (USD Millions), (2013-2015)
• Table 22: Anal Cancer Japan Market (USD Millions), (2016-2023)
• Table 23: Anal Cancer ROW Market (USD Millions), (2013-2015)
• Table 24: Anal Cancer ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Anal Cancer Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Anal Cancer (2013-2023)
• Figure 3: Anal Cancer Global Market (USD Millions), (2013-2015)
• Figure 4: Anal Cancer Global Market (USD Millions), (2016-2023)
• Figure 5: Anal Cancer US Market (USD Millions), (2013-2015)
• Figure 6: Anal Cancer US Market (USD Millions), (2016-2023)
• Figure 7: Anal Cancer Germany Market (USD Millions), (2013-2015)
• Figure 8: Anal Cancer Germany Market (USD Millions), (2016-2023)
• Figure 9: Anal Cancer United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Anal Ca+M76ncer United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Anal Cancer France Market (USD Millions), (2013-2015)
• Figure 12: Anal Cancer France Market (USD Millions), (2016-2023)
• Figure 13: Anal Cancer Italy Market (USD Millions), (2013-2015)
• Figure 14: Anal Cancer Italy Market (USD Millions), (2016-2023)
• Figure 15: Anal Cancer Spain Market (USD Millions), (2013-2015)
• Figure 16: Anal Cancer Spain Market (USD Millions), (2016-2023)
• Figure 17: Anal Cancer Japan Market (USD Millions), (2013-2015)
• Figure 18: Anal Cancer Japan Market (USD Millions), (2015-2023)
• Figure 19: Anal Cancer ROW Market (USD Millions), (2013-2015)
• Figure 20: Anal Cancer ROW Market (USD Millions), (2016-2023)
【掲載企業】
• Advaxis Inc.
• Amgen Inc.
• Eli Lilly and Company
• Genticel S.A.
• ISA Pharmaceuticals B.V.
• Novartis AG
• Oryx GmbH & Co. KG
• PDS Biotechnology Corporation
• Sun Pharma Advanced Research Company Ltd.
• Taiwan Liposome Company Ltd.
【レポートのキーワード】
肛門がん
【免責事項】
https://www.marketreport.jp/reports-disclaimer